Abstract Background Oral administration of lotilaner flavoured chewable tablets (Credelio™, Elanco) to dogs has been shown to provide a rapid onset of killing activity of infesting ticks, with sustained efficacy for at least 35 days. A study was undertaken in Europe to confirm lotilaner’s safety and anti-tick efficacy in client-owned dogs. Methods In this assessor-blinded study, dogs were enrolled at 19 clinics in Germany, Hungary and Portugal. Qualifying households with no more than three dogs were randomized in an approximate 2:1 ratio to a lotilaner or fipronil/(S)-methoprene (FSM) (Frontline® Combo Spot-on, Merial) treatment group. One household dog with at least three live attached ticks was the primary dog. Treatments were dispensed D...
Abstract Background Lotilaner is a new isoxazoline developed as an oral ectoparasiticide for cats an...
AbstractTwo randomised, blinded, multi-centered field studies were conducted in Europe to demonstrat...
Abstract Background Lotilaner (Credelio™, Elanco) is a novel isoxazoline that provides rapid speed o...
Abstract Background There is a continuing need for novel approaches to tick control in dogs. One suc...
Abstract Background Effective control of tick infestations on dogs is important to reduce the risk o...
Abstract Background From three days following host attachment, the Australian paralysis tick, Ixodes...
Abstract Background With the geographical expansion of tick species and increased recognition of pat...
Abstract Background Lotilaner is a novel isoxazoline developed for oral administration to dogs. In l...
Abstract Background Preclinical studies have shown that the novel isoxazoline, lotilaner (Credelio™,...
Abstract Background The ixodid tick Amblyomma cajennense (sensu lato) complex, widespread throughout...
Abstract Background There is a continuing need for novel approaches to tick infestations treatment a...
Abstract Background Lotilaner, approved for dogs as a chewable tablet formulation, has separately be...
BACKGROUND: Tick-borne infections resulting from regular tick infestation in dogs are a common vete...
Abstract Background The speed with which acaricides paralyze and kill ticks is relevant to impeding ...
Abstract Background The isoxazoline fluralaner is effective for prevention of Babesia canis transmis...
Abstract Background Lotilaner is a new isoxazoline developed as an oral ectoparasiticide for cats an...
AbstractTwo randomised, blinded, multi-centered field studies were conducted in Europe to demonstrat...
Abstract Background Lotilaner (Credelio™, Elanco) is a novel isoxazoline that provides rapid speed o...
Abstract Background There is a continuing need for novel approaches to tick control in dogs. One suc...
Abstract Background Effective control of tick infestations on dogs is important to reduce the risk o...
Abstract Background From three days following host attachment, the Australian paralysis tick, Ixodes...
Abstract Background With the geographical expansion of tick species and increased recognition of pat...
Abstract Background Lotilaner is a novel isoxazoline developed for oral administration to dogs. In l...
Abstract Background Preclinical studies have shown that the novel isoxazoline, lotilaner (Credelio™,...
Abstract Background The ixodid tick Amblyomma cajennense (sensu lato) complex, widespread throughout...
Abstract Background There is a continuing need for novel approaches to tick infestations treatment a...
Abstract Background Lotilaner, approved for dogs as a chewable tablet formulation, has separately be...
BACKGROUND: Tick-borne infections resulting from regular tick infestation in dogs are a common vete...
Abstract Background The speed with which acaricides paralyze and kill ticks is relevant to impeding ...
Abstract Background The isoxazoline fluralaner is effective for prevention of Babesia canis transmis...
Abstract Background Lotilaner is a new isoxazoline developed as an oral ectoparasiticide for cats an...
AbstractTwo randomised, blinded, multi-centered field studies were conducted in Europe to demonstrat...
Abstract Background Lotilaner (Credelio™, Elanco) is a novel isoxazoline that provides rapid speed o...